Newsletter

Biotech

Random
A physician holding a syringe.

Novavax COVID-19 Vaccine Advances to Phase 1/2 Human Trials

A person holding a laboratory test for the coronavirus that causes COVID-19.

Altimmune Partners with UAB to Develop Intranasal COVID-19 Vaccine

A syringe, pills, and a face mask resting on a surface. The syringe may contain the HIV vaccine Vesatolimod.

Gilead’s TLR7 Agonist Vesatolimod Enhances Immune Response to HIV

Scientists working in a laboratory.

Vir Reports Publication Detailing Coronavirus Neutralizing Antibody S309

White pills resting on a pink surface.

AVEO Oncology Submits NDA to FDA for Tivozanib in Renal Carcinoma

Four syringes resting on a blue surface.

Jounce Presents Preclinical Data for LILRB2 Inhibitor JTX-8064

A collection of white and black medications resting on a table.

FDA: RMAT Designation to Vertex and CRISPR’s TDT Therapy CTX001

Entyvio pen and injector for subcutaneous administration.

Entyvio SC Approved in Europe as Maintenance Therapy for UC and...

A woman wearing a face mask standing near a building. The COVID-19 vaccine developed by Moderna could lead to the end of the coronavirus pandemic.

Moderna COVID-19 Vaccine: Top 5 Things to Know and Latest Updates

Pills resting on a surface as a reference to the drug remdesivir by Gilead Sciences. The medication is currently being evaluated for the treatment of COVID-19 in phase 3 clinical trials.

Gilead Completes Phase 3 Trial of Remdesivir for Treatment of COVID-19

123...5Page 1 of 5

Featured Articles

Contact

Connect

Follow Us

ImmunoFrontiers © 2019-2021. All Rights Reserved. We are a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites.

error: Content is protected.